Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia.

CONCLUSION: The optimized in-house PCR assays for the<br />detection of FLT3-ITD, FLT3-D835 and NPM1 mutations in AML patients were robust, less labour intensive and cost<br />effective. These assays can be used as diagnostic tools for mutation detection in AML patients since identification of<br />these mutations are important for prognostication and optimization of patient care. PMID: 31244296 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research